Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (TheStreet) -- CHANGE IN RATINGS
Auxilium Pharmaceuticals (AUXL) rated new Buy at UBS. $30 price target. The company's two lead products are underappreciated by the market.
CH Robinson (CHRW) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $86 price target. Company is leveraged to tighter trucking capacity.Cisco Systems (CSCO) downgraded at Auriga from Buy to Hold, Auriga USA said. $19 price target. Company is likely to face increased competition in the coming quarters. CVR Energy (CVI) initiated at Credit Suisse with an Outperform rating and $30 price target. Strong earnings power not priced in, Credit Suisse said. Dr. Pepper Snapple (DPS) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call, as the company lacks near-term catalysts. $40 price target. FirstEnergy (FE) upgraded at Jefferies from Underperform to Hold. $38 price target. Expect the company to maintain its investment grade rating. Finish Line (FINL) upgraded at Citigroup to Buy from Hold. Margin expansion on strong footwear cycle. Price target increased to $25 from $22. Fifth Third (FITB) upgraded at Baird from Neutral to Outperform, Robert Baird said. $17 price target. Large-cap banks appear oversold and the stock is trading at just 9x expected 2012 earnings. Google (GOOG) downgraded at Credit Suisse to Hold from Buy as it is now a "show-me story," Credit Suisse said. Price target lowered to $650 from $750. Hasbro (HAS) upgraded at Morgan Joseph from Hold to Buy, Morgan Joseph said. $54 price target. Company has handled its inventory issues and has several potential near-term catalysts. Hasbro (HAS) estimates, target lowered at Goldman. Shares of HAS now seen reaching $58, according to Goldman Sachs. Estimates also cut, as the company is realizing higher costs from its TV venture. Buy rating. Harley-Davidson (HOG) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. $44 price target. Domestic bike demand is stabilizing. Impax Labs (IPXL) rated new Neutral at UBS. $30 price target. Company is facing increased generic competition. Rosetta Resources (ROSE) upgraded at Canaccord to Buy, Canaccord Genuity said. Valuation call, based on a $53 price target.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV